Drug Trial Radar · NCT02478840
Evaluation of Long-term Efficacy of Treatment With Lamazym
Last checked: Nov 20, 2026Latest source record: Nov 20, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
18
Actual
Start
Feb 2015
Primary completion
Jun 2015
Study completion Jun 2015
Sponsor
- Lead sponsor
- Zymenex A/SIndustry
- Sponsor type
- Industry
- First posted
- Jun 23, 2015
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The overall objective is to evaluate the long-term efficacy of Lamazym i.v. treatment in patients with alpha-Mannosidosis previously enrolled in Lamazym trials and currently receiving the treatment according to the AfterCare Program.
Conditions
- Alpha-Mannosidosis
Interventions
LamazymDrug
recombinant human alpha-mannosidase
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline in reduction of oligosaccharides in serumTime frame: Baseline evaluation prior to first dose compared to evaluation after one, two or four years of treatment
- Change from baseline in 3 Minutes Stair Climb Test (3MSCT)Time frame: Baseline evaluation prior to first dose compared to evaluation after one, two or four years of treatment
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Center for Metabolic Diseases, Department of Clinical Genetics, Juliane Marie Centre, Copenhagen University Hospital, Blegdamsvej 9
Copenhagen, Denmark
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.